Ropes & Gray LLP

Ropes & Gray LLP is particularly well versed in handling complex cross-border licensing agreements, and is also a name to note for transactions in the life sciences space. Additionally, the practice offers extensive expertise across a wide range of litigation, representing clients facing IP disputes and product liability class action, and is able to support clients seeking FDA approval for their products. The practice is headed jointly by transactional specialists Marc Rubenstein and Michael Beauvais, both of whom are based in Boston and maintain a broad transaction practice encompassing IPOs, licensing agreements and M&As in the sector, and Washington DC’s Gregory Levine, who focuses predominantly on assisting pharmaceutical, biotech and medical devices clients in navigating the FDA’s regulatory regime. Kellie Combs, also operating out of the capital, is noted for her knowledge of the Food, Drug, and Cosmetic Act and the Public Health Service Act, FDA promotional rules and the regulation of digital health systems.